Eris Lifesciences has informed that a Meeting of the Board of Directors of the company is scheduled on Monday, May 19, 2025, to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended March 31, 2025. Further, as informed by them vide letter dated March 26, 2025, the trading window has been already closed from April 01, 2025, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company for the purpose of Board Meeting.
The above information is a part of company’s filings submitted to BSE.
